Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.

How to buy Syneos Health stock | 60.75

Own Syneos Health stock in just a few minutes.

Posted

Fact checked

Syneos Health, Inc is a diagnostics & research business based in the US. Syneos Health shares (SYNH) are listed on the NASDAQ and all prices are listed in US Dollars. Syneos Health employs 24,000 staff and has a trailing 12-month revenue of around USD$4.6 billion.

How to buy shares in Syneos Health

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Syneos Health. Find the stock by name or ticker symbol: SYNH. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Syneos Health reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$60.75, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Syneos Health, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Syneos Health. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Syneos Health's share price?

Since the stock market crash in March caused by coronavirus, Syneos Health's share price has had significant negative movement.

Its last market close was USD$60.75, which is 14.22% down on its pre-crash value of USD$70.82 and 102.37% up on the lowest point reached during the March crash when the shares fell as low as USD$30.02.

If you had bought USD$1,000 worth of Syneos Health shares at the start of February 2020, those shares would have been worth USD$546.87 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$982.33.

Syneos Health share price

Use our graph to track the performance of SYNH stocks over time.

Syneos Health shares at a glance

Information last updated 2020-10-16.
Latest market closeUSD$60.75
52-week rangeUSD$30.02 - USD$74.25
50-day moving average USD$57.7351
200-day moving average USD$56.5738
Wall St. target priceUSD$73.46
PE ratio 33.9553
Dividend yield N/A (0%)
Earnings per share (TTM) USD$1.773

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks
N/A
0%
A free way to invest in stocks, ETFs and crypto.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
Tastyworks
$0
Stocks, Options, ETFs, Futures
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Syneos Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Syneos Health price performance over time

Historical closes compared with the close of $60.75 from 2020-10-16

1 week (2020-10-16) 60.75
1 month (2020-09-25) 17.78%
3 months (2020-07-24) 2.05%
6 months (2020-04-24) 20.42%
1 year (2019-10-25) 14.13%
2 years (2018-10-25) 33.66%
3 years (2017-10-25) 9.46%
5 years (2015-10-23) 52.18%

Is Syneos Health under- or over-valued?

Valuing Syneos Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Syneos Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Syneos Health's P/E ratio

Syneos Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, Syneos Health shares trade at around 34x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Syneos Health's PEG ratio

Syneos Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0174. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Syneos Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Syneos Health's EBITDA

Syneos Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$550 million.

The EBITDA is a measure of a Syneos Health's overall financial performance and is widely used to measure a its profitability.

Syneos Health financials

Revenue TTM USD$4.6 billion
Operating margin TTM 6.95%
Gross profit TTM USD$1 billion
Return on assets TTM 2.68%
Return on equity TTM 6.44%
Profit margin 4.11%
Book value $28.778
Market capitalisation USD$6.3 billion

TTM: trailing 12 months

Shorting Syneos Health shares

There are currently 6.1 million Syneos Health shares held short by investors – that's known as Syneos Health's "short interest". This figure is 5.5% up from 5.8 million last month.

There are a few different ways that this level of interest in shorting Syneos Health shares can be evaluated.

Syneos Health's "short interest ratio" (SIR)

Syneos Health's "short interest ratio" (SIR) is the quantity of Syneos Health shares currently shorted divided by the average quantity of Syneos Health shares traded daily (recently around 979696.33173844). Syneos Health's SIR currently stands at 6.27. In other words for every 100,000 Syneos Health shares traded daily on the market, roughly 6270 shares are currently held short.

However Syneos Health's short interest can also be evaluated against the total number of Syneos Health shares, or, against the total number of tradable Syneos Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Syneos Health's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Syneos Health shares in existence, roughly 60 shares are currently held short) or 0.0989% of the tradable shares (for every 100,000 tradable Syneos Health shares, roughly 99 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Syneos Health.

Find out more about how you can short Syneos Health stock.

Syneos Health share dividends

We're not expecting Syneos Health to pay a dividend over the next 12 months.

Syneos Health share price volatility

Over the last 12 months, Syneos Health's shares have ranged in value from as little as $30.02 up to $74.25. A popular way to gauge a stock's volatility is its "beta".

SYNH.US volatility(beta: 1.74)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Syneos Health's is 1.743. This would suggest that Syneos Health's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Syneos Health overview

Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services, including medication adherence, communications solutions, and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. Syneos Health, Inc. has a strategic agreement with Daiichi Sankyo, Inc. for the development of Daiichi Sankyo'S Adc oncology pipeline. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site